Magri, V., Scagnoli, S., Piesco, G. and Pomati, G. 2018. Lapatinib as second-line treatment after the double block pertuzumab-trastuzumab: a case report: Lapatinib in II linea dopo il doppio blocco pertuzumab-trastuzumab: un caso clinico. AboutOpen. 4, 1 (Oct. 2018), 185–190. DOI:https://doi.org/10.19156/abtpn.2018.0071.